Utility of the neutrophil-to-lymphocyte ratio extends to patients from East Asia
Seong-Keun Yoo, Jinha Hwang, Jung Yong Hong, Seung Tae Kim, Se Hoon Park, Joon Oh Park, Jeeyun Lee
Seong-Keun Yoo, Jinha Hwang, Jung Yong Hong, Seung Tae Kim, Se Hoon Park, Joon Oh Park, Jeeyun Lee
View: Text | PDF
Letter to the Editor Clinical Research Oncology

Utility of the neutrophil-to-lymphocyte ratio extends to patients from East Asia

Abstract

Authors

Seong-Keun Yoo, Jinha Hwang, Jung Yong Hong, Seung Tae Kim, Se Hoon Park, Joon Oh Park, Jeeyun Lee

×

Figure 1

Utility of NLR in Korean patients.

Options: View larger image (or click on image) Download as PowerPoint
Utility of NLR in Korean patients. (A) Kaplan-Meier curves comparing OS ...
(A) Kaplan-Meier curves comparing OS between pretreatment NLR groups. P values are from 2-sided log-rank tests. (B) Forest plot of hazard ratios (HRs) for OS from a multivariable Cox proportional hazards model. BMI, body mass index. (C) HRs for OS across pretreatment NLR groups defined by various candidate cutoffs (1.0–10.0 in 0.5-unit increments). Solid lines indicate the estimated HRs; shaded bands represent the 95% CIs. (D) Kaplan-Meier curves comparing duration of treatment between pre-treatment NLR groups. P values are from 2-sided log-rank tests.